Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
Part of paid clinical trials in Redwood City, California.
- Sponsor
- Aparna Goel
- Study ID
- NCT05295680
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Primary Sclerosing Cholangitis
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hymecromone — DRUGHymecromone 400 mg 3 times daily by mouth.
Study Details
Primary objective: To evaluate the efficacy of hymecromone plus standard of care compared with standard of care alone in the treatment of adolescents and adults with primary sclerosing cholangitis (PSC). Secondary objectives: To evaluate the change in Alkaline Phosphatase (ALP) from baseline to 6 months post-treatment following treatment with hymecromone plus standard of care compared with standard of care. To evaluate changes in biomarkers of PSC disease during hymecromone treatment, namely: (a) fibrotic effect (FibroScan); (b) inflammatory biomarkers (serum Hyaluronan (HA)); and, (c) T-cell count.
Key Dates
- Start date
- May 10, 2023
- Status verified
- Nov 2024
- Primary completion
- May 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: HymecromoneParticipants will receive Hymecromone for six months + Standard Of Care (SOC), and will be followed for an additional nine months.
- No Intervention: Standard Of Care (SOC)Participants will receive Standard Of Care (SOC), and will be followed for 15 months.
Primary Outcome Measure
Change in serum gamma-glutamyltransferase (GGT) levels [ Time Frame: Baseline to Month 6 ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford Clinic | Redwood City | California | 94063 | |
| Stanford Clinic | Stanford | California | 94305 |
Find similar trials in Redwood City, CA
Related Studies
- Treating Primary Sclerosing Cholangitis and Biliary Atresia With VancomycinPHASE1 · Recruiting · Sacramento Pediatric Gastroenterology · Sacramento, California
- Primary Sclerosing Cholangitis in ChildrenRecruiting · Arbor Research Collaborative for Health · Los Angeles, California
- A-LiNK: Improving Outcomes in Autoimmune Liver DiseaseRecruiting · Children's Hospital Medical Center, Cincinnati · Palo Alto, California
- Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics StudyEARLY_PHASE1 · Recruiting · Stanford University · Stanford, California